Mauricio G. Cohen
A5011361567- Acute Myocardial Infarction Research
- Cardiac Valve Diseases and Treatments
- Cardiac Imaging and Diagnostics
- Coronary Interventions and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Cardiac, Anesthesia and Surgical Outcomes
- Vascular Procedures and Complications
- Venous Thromboembolism Diagnosis and Management
- Mechanical Circulatory Support Devices
- Infective Endocarditis Diagnosis and Management
- Cardiac Arrest and Resuscitation
- Cardiac Structural Anomalies and Repair
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Central Venous Catheters and Hemodialysis
- Aortic Disease and Treatment Approaches
- Cardiac pacing and defibrillation studies
- Cardiac Health and Mental Health
- Health Systems, Economic Evaluations, Quality of Life
- Peripheral Artery Disease Management
- Cardiac electrophysiology and arrhythmias
- Cardiac Arrhythmias and Treatments
- Cardiovascular Health and Risk Factors
- Healthcare Policy and Management
Cleveland Clinic Florida
2023-2024
Jackson Memorial Hospital
2013-2023
University of Miami
2014-2023
University of Miami Hospital
2013-2023
University of Miami Health System
2019-2023
Emory University
2020-2021
Memorial Hospital
2021
Cardiovascular Research Center
2021
Association of Chartered Certified Accountants
2020-2021
Tallahassee Memorial HealthCare
2021
Kristian Thygesen∗ (Denmark) Joseph S. Alpert∗ (USA) Allan Jaffe (USA) Bernard R. Chaitman (USA) Jeroen J. Bax (The Netherlands) David A. Morrow (USA) Harvey D. White∗ (New Zealand) Hans Mickley (Denmark) Filippo Crea (Italy) Frans Van de Werf (Belgium) Chiara Bucciarelli-Ducci (
Background— Radial access for percutaneous coronary intervention (r-PCI) is associated with reduced vascular complications; however, previous reports have shown that <2% of (PCI) procedures in the United States are performed via radial approach. Our aims were to evaluate temporal trends r-PCI and compare procedural outcomes between transfemoral PCI. Methods Results— We conducted a retrospective cohort study from CathPCI registry (n=2 820 874 1381 sites) January 2007 September 2012....
There are limited data on coronary obstruction following transcatheter valve-in-valve (ViV) implantation inside failed aortic bioprostheses. The objectives of this study were to determine the incidence, predictors, and clinical outcomes in ViV procedures. A total 1612 procedures from Valve-in-Valve International Data (VIVID) Registry evaluated. subject centralized blinded corelab computed tomography (CT) analysis a subset patients. virtual valve ostium distance (VTC) was determined. 37...
Although human mesenchymal stem cells (hMSCs) have been tested in ischemic cardiomyopathy, few studies exist chronic nonischemic dilated cardiomyopathy (NIDCM).The authors conducted a randomized comparison of safety and efficacy autologous (auto) versus allogeneic (allo) bone marrow-derived hMSCs NIDCM.Thirty-seven patients were to either allo- or auto-hMSCs 1:1 ratio. Patients recruited between December 2011 July 2015 at the University Miami Hospital. received (100 million) by...
Patients with severe coronary artery disease a clinical indication for revascularization but who are at high procedural risk because of patient comorbidities, complexity anatomy, and/or poor hemodynamics represent an understudied and potentially underserved population. Through advances in percutaneous interventional techniques technologies improvements selection, current intervention may allow appropriate patients to benefit safely from procedures that might not have been offered the past....
Rationale: Cell dose and concentration play crucial roles in phenotypic responses to cell-based therapy for heart failure. Objective: To compare the safety efficacy of 2 doses allogeneic bone marrow–derived human mesenchymal stem cells identically delivered patients with ischemic cardiomyopathy. Methods Results: Thirty cardiomyopathy received a blinded manner either 20 million (n=15) or 100 via transendocardial injection (0.5 cc per × 10 injections patient). Patients were followed 12 months...
Background— Black patients with acute myocardial infarction are less likely than whites to receive coronary interventions. It is unknown whether racial disparities exist for other treatments non–ST-segment elevation syndromes (NSTE ACS) and how different affect outcomes. Methods Results— Using data from 400 US hospitals participating in the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes Early Implementation ACC/AHA Guidelines?) National Quality...
The relationship between operator or institutional volume and outcomes among patients undergoing percutaneous coronary interventions (PCI) is unclear.Cross-sectional study based on the Healthcare Cost Utilization Project's Nationwide Inpatient Sample 2005 to 2009. Subjects were identified by International Classification of Diseases, 9(th) Revision, Clinical Modification procedure code, 36.06 36.07. Annual volumes calculated using unique identification numbers then divided into quartiles....
Racial/ethnic differences in cardiovascular care have been well documented. We sought to determine whether racial/ethnic evidence-based acute myocardial infarction persist among hospitals participating a national quality improvement program.